glutathione s transferase mu 1 Human S‑Transferase 1/GSTM1 Antibody MAB6894: R&D Systems Validated Applications Human Glutathione S‑Transferase mu 1/GS

When the soluble ionic form of the drug diffuses from the stagnant diffusion layer into the bulk of the solution whose pH is low, it is transformed into its free acid form having lesser aqueous solubility at the lower pH of the bulk solution

See also our guide to peptide storage best practices

The nature of the R group determines each amino acid's chemical properties and behavior in protein structures [13, 14]

Jul 16, 2026 FDA Publishes All 7 Briefing Documents Ahead of the July 2026 PCAC Meeting The FDA has posted all seven scientific briefing documents for the July 2324, 2026 Pharmacy Compounding Advisory Committee meeting an unusually clear window into the agency's current thinking on peptide safety, efficacy, and characterization